Daily as of 3 Nov 16:00 ET
- Price
- below both $14.57 vs 50 $16.21 / 200 $18.24
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 16 Oct 2026 · projected 29 bars out
JBIO | Jade BiosciencesNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$14.57
+$0.64 (+4.59%)
Jade Biosciences (JBIO) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2026.
The 50 SMA has sat below the 200 on the daily since Oct 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits below the 50 and the 200 on the daily and between the two on the 4-hour.
Timeframe summary
Weekly
No weekly data
4-hour as of 3 Nov 16:00 ET
- Price
- between the two $14.57 vs 50 $14.14 / 200 $18.54
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 15 Sep 2026 · projected 22 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 16 Oct 2026 | 💀Death steep | daily | 29 bars out | Not tested |
| 15 Sep 2026 | 💀Death | 4-hour | 22 bars out | Not tested |
About JBIO
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$13.2M
4-hour coverageYes, since Oct 2025
History on recordSince 2026
SectorHealthcare
Cap bandsmall